NCT06020430View on ClinicalTrials.gov

Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy

NARecruitingINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

February 8, 2024

Primary Completion Date

February 8, 2026

Study Completion Date

October 8, 2027

Conditions
Non Small Cell Lung CancerLocally AdvancedRadiotherapyImmunotherapy
Interventions
RADIATION

CTV omitted or delineated

Patients who responded to the induction therapy (immunotherapy and chemotherapy) were randomly (1:1) assigned into CTV-omitted radical radiotherapy group or CTV-delineated radiotherapy group.

Trial Locations (1)

430079

RECRUITING

Hubei Cancer Hospital, Wuhan

All Listed Sponsors
lead

Hubei Cancer Hospital

OTHER